MEDP实时信号 | 通过Getagraph.com最大化利润

出售 203 min ago

@ $391.17

发出时间: 2 May 2024 @ 01:20

回报率: 1.71%

上一信号: Apr 30 - 23:52

上一信号: 购买

回报率: -0.83 %

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 04:00):

Stats
今日成交量	280 957
平均成交量	284 201
市值	12.33B
EPS	$0 ( 2024-04-22 )
下一个收益日期	( $2.50 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	40.64
ATR14	$16.42 (4.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Troendle August J.	Sell	15 102	Common Stock
2024-04-30	Troendle August J.	Sell	1 828	Common Stock
2024-03-31	Kraft Robert O.	Buy	72	Common Stock
2024-03-31	Kraft Robert O.	Sell	72	Restricted Stock Unit
2024-03-31	Mccarthy Cornelius P. Iii	Buy	63	Common Stock

INSIDER POWER
-94.52
Last 100 transactions
Buy: 68 908 \| Sell: 2 488 859

音量相关性

長: 0.79 (moderate)

短: -0.47 (neutral)

Signal:(41) Neutral

Medpace Holdings Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Medpace Holdings Inc 相关性 - 货币/商品

0.75
( moderate )

0.77
( moderate )

-0.66
( moderate negative )

0.59
( weak )

-0.25
( neutral )

Medpace Holdings Inc 财务报表

Annual	2023
营收:	$1.89B
毛利润:	$524.51M (27.81 %)
EPS:	$9.20

FY	2023
营收:	$1.89B
毛利润:	$524.51M (27.81 %)
EPS:	$9.20

FY	2022
营收:	$1.46B
毛利润:	$432.44M (29.62 %)
EPS:	$7.57

FY	2021
营收:	$1.14B
毛利润:	$328.16M (28.73 %)
EPS:	$5.08

Financial Reports:

No articles found.

Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.